DeepMind Spinout Isomorphic Labs Raises $2.1 Billion to Design Drugs With AI - Bloomberg.com
10/10Isomorphic Labs, a DeepMind spinout, raised $2.1 billion in funding on May 12, 2026, to advance AI-driven drug discovery. This significant investment underscores the growing importance of artificial intelligence in pharmaceutical research and development.
